Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bittium Oyj Director's Dealing 2022

Mar 29, 2022

3258_rns_2022-03-29_f20af24e-d32e-4e3c-8f55-96a69986e322.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Bittium

Bittium Corporation: Notification of Manager's Transactions - Jari Sankala

Stock exchange release

Free for publication on March 29, 2022 at 09:45 am (CEST+1)

Bittium Corporation: Notification of Manager's Transactions - Jari Sankala

Person subject to the notification requirement

Name: Jari Sankala

Position: Other senior manager

Issuer: Bittium Corporation

LEI: 743700NFG5W5I59OVX65

Notification type: INITIAL NOTIFICATION

Reference number: 12181/7/6

Transaction date: 2022-03-25

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: SHARE

ISIN: FI0009007264

Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details

(1): Volume: 47 Unit price: 0 EUR
(2): Volume: 91 Unit price: 0 EUR
(3): Volume: 127 Unit price: 0 EUR
(4): Volume: 153 Unit price: 0 EUR
(5): Volume: 650 Unit price: 0 EUR
(6): Volume: 46 Unit price: 0 EUR
(7): Volume: 534 Unit price: 0 EUR


Aggregated transactions

(7): Volume: 1648 Volume weighted average price: 0 EUR

Oulu, Finland, March 29, 2022

Bittium Corporation

The Board of Directors

Further information

Kari Jokela

CLO

Bittium Corporation

Tel. +358 40 344 3507

Distribution

Nasdaq Helsinki Oy

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com